Born in December 1978, Dr. Lin Xi has been working in the Ultrasound Diagnosis and Interventional Treatment at Sun Yat-sen University Cancer Center since she graduated from undergraduate program from Sun Yat-sen University in 2002. She was conferred upon the degree of Master of Clinical Medicine in 2008 and the degree of Doctor of Clinical Medicine in 2011 by Sun Yat-sen University. She furthered her studies in Breast Screening and Diagnostic Imaging Centre at University of Western Australia between September 2010 and September 2011. She has been an associate chief physician in Ultrasound Diagnosis and Interventional Treatment since January 2013, engaging herself in ultrasound diagnosis and interventional treatment of cancer. She specializes in ultrasound diagnosis and interventional treatment of such cancer as hepatobiliary cancer, urinary system cancer, breast cancer, thyroid cancer, lymphoma and gynecological cancers, with considerable experience of in-depth research into early diagnosis of breast cancer and other superficial organ tumors.

Radiology; breast cancer

She graduated from undergraduate program from Zhongshan School of Medicine, Sun Yat-sen University in 2002, and was conferred upon the degree of Master of Clinical Medicine in 2008 and the degree of Doctor of Clinical Medicine in 2011 by Sun Yat-sen University.

1. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound. Lin X, Wang J, Han F, Fu J, Li A. Eur J Radiol. 2012 May;81(5):873-8. (lead author)

2. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J, Song L. Clin Cancer Res. 2011 May 15;17(10):3089-99. (co-lead author)

3. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis. An X, Lin X, Wang FH, Goodman K, Cai PQ, Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, Pan ZZ, Ding PR. Eur J Cancer. 2013 Mar;49(4):843-51 (co-lead author)

4. Quantitative assessment of spinal cord perfusion by using contrast-enhanced ultrasound in a porcine model with acute spinal cord contusion. Huang L, Lin X, Tang Y, Yang R, Li AH, Ye JC, Chen K, Wang P, Shen HY. Spinal Cord. 2013 Mar;51(3):196-201. (co-lead author)

5. Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. Chen X, Ying Z, Lin X, Lin H, Wu J, Li M, Song L. J Clin Invest. 2013 Jun 3;123(6):2576-89

6. Nkx2-8 downregulation promotes angiogenesis and activates NF-κB in esophageal cancer. Lin C, Song L, Gong H, Liu A, Lin X, Wu J, Li M, Li J. Cancer Res. 2013 Jun 15;73(12):3638-48.

7. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X. Biochem Biophys Res Commun. 2012 Aug 24;425(2):127-33

Last Updated on: 2013,by International Office, Sun Yat-sen University Cancer Center